APOLIPOPROTEIN B - ANVISA Registration 10350840023

Access comprehensive regulatory information for APOLIPOPROTEIN B in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840023 and manufactured by DIASYS DIAGNOSTIC SYSTEMS GMBH. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTICS DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10350840023
Registration Details
ANVISA Registration Number: 10350840023
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

APO B FS
Risk Class II

Registration Details

10350840023

250000243999878

02220795000179

Company Information

Germany
PT: ALEMANHA

Dates and Status

Oct 22, 1998

VIGENTE

09/18/2025 19:00:01